Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

Ductal carcinoma in situ: state of the science and roadmap to advance the field.

Kuerer HM, Albarracin CT, Yang WT, Cardiff RD, Brewster AM, Symmans WF, Hylton NM, Middleton LP, Krishnamurthy S, Perkins GH, Babiera G, Edgerton ME, Czerniecki BJ, Arun BK, Hortobagyi GN.

J Clin Oncol. 2009 Jan 10;27(2):279-88. doi: 10.1200/JCO.2008.18.3103. Epub 2008 Dec 8. Review.

PMID:
19064970
[PubMed - indexed for MEDLINE]
Free Article
2.

Ductal carcinoma in situ of the breast: histological classification and genetic alterations.

van de Vijver MJ.

Recent Results Cancer Res. 1998;152:123-34. Review.

PMID:
9928552
[PubMed - indexed for MEDLINE]
3.

Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.

Schuetz CS, Bonin M, Clare SE, Nieselt K, Sotlar K, Walter M, Fehm T, Solomayer E, Riess O, Wallwiener D, Kurek R, Neubauer HJ.

Cancer Res. 2006 May 15;66(10):5278-86.

PMID:
16707453
[PubMed - indexed for MEDLINE]
Free Article
4.

Molecular grading of ductal carcinoma in situ of the breast.

Balleine RL, Webster LR, Davis S, Salisbury EL, Palazzo JP, Schwartz GF, Cornfield DB, Walker RL, Byth K, Clarke CL, Meltzer PS.

Clin Cancer Res. 2008 Dec 15;14(24):8244-52. doi: 10.1158/1078-0432.CCR-08-0939.

PMID:
19088042
[PubMed - indexed for MEDLINE]
Free Article
5.

Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.

Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM.

Breast Cancer Res. 2008;10(5):R87. doi: 10.1186/bcr2157. Epub 2008 Oct 17.

PMID:
18928525
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Overview of the biology and management of ductal carcinoma in situ of the breast.

Frykberg ER, Bland KI.

Cancer. 1994 Jul 1;74(1 Suppl):350-61. Review.

PMID:
8004607
[PubMed - indexed for MEDLINE]
7.

Ductal carcinoma in situ of the breast.

Fonseca R, Hartmann LC, Petersen IA, Donohue JH, Crotty TB, Gisvold JJ.

Ann Intern Med. 1997 Dec 1;127(11):1013-22. Review.

PMID:
9412283
[PubMed - indexed for MEDLINE]
8.

Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor.

Nielsen BS, Rank F, Illemann M, Lund LR, Danø K.

Int J Cancer. 2007 May 15;120(10):2086-95.

PMID:
17290405
[PubMed - indexed for MEDLINE]
9.

Molecular markers and therapeutic targets in ductal carcinoma in situ.

Boland GP, Knox WF, Bundred NJ.

Microsc Res Tech. 2002 Oct 1;59(1):3-11. Review.

PMID:
12242692
[PubMed - indexed for MEDLINE]
10.

Classification of ductal carcinoma in situ by gene expression profiling.

Hannemann J, Velds A, Halfwerk JB, Kreike B, Peterse JL, van de Vijver MJ.

Breast Cancer Res. 2006;8(5):R61.

PMID:
17069663
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A proposal for the histopathological diagnosis of ductal carcinoma in situ of the breast.

Moriya T, Kasami M, Akiyama F, Ichihara S, Kurosumi M, Tsuda H, Umemura S, Akashi-Tanaka S, Imamura H, Iwase H, Shin E, Harada Y, Mitsuyama S, Ohuchi N.

Breast Cancer. 2000;7(4):321-5.

PMID:
11114858
[PubMed - indexed for MEDLINE]
12.

Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma.

Qi L, Bart J, Tan LP, Platteel I, Sluis Tv, Huitema S, Harms G, Fu L, Hollema H, Berg Av.

BMC Cancer. 2009 May 28;9:163. doi: 10.1186/1471-2407-9-163.

PMID:
19473551
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The molecular journey from ductal carcinoma in situ to invasive breast cancer.

Wiechmann L, Kuerer HM.

Cancer. 2008 May 15;112(10):2130-42. doi: 10.1002/cncr.23430. Review.

PMID:
18383519
[PubMed - indexed for MEDLINE]
Free Article
14.

BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.

Rosen EL, Smith-Foley SA, DeMartini WB, Eby PR, Peacock S, Lehman CD.

Breast J. 2007 Nov-Dec;13(6):545-50.

PMID:
17983393
[PubMed - indexed for MEDLINE]
15.

Evaluation of MUC1 splice variants as prognostic markers in patients with ductal carcinoma in situ of the breast.

Schmid BC, Rudas M, Fabjani G, Speiser P, Kaserer K, Leodolter S, Zeillinger R.

Oncol Rep. 2003 Nov-Dec;10(6):1981-5.

PMID:
14534730
[PubMed - indexed for MEDLINE]
16.

Ductal carcinoma in situ. Implications for screening mammography.

Feig SA.

Radiol Clin North Am. 2000 Jul;38(4):653-68, vii. Review.

PMID:
10943269
[PubMed - indexed for MEDLINE]
17.

RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.

Subramaniam MM, Chan JY, Soong R, Ito K, Ito Y, Yeoh KG, Salto-Tellez M, Putti TC.

Breast Cancer Res Treat. 2009 Jan;113(1):113-21. doi: 10.1007/s10549-008-9917-4. Epub 2008 Feb 7.

PMID:
18256927
[PubMed - indexed for MEDLINE]
18.

GSTP1 promoter hypermethylation is an early event in breast carcinogenesis.

Lee JS.

Virchows Arch. 2007 Jun;450(6):637-42. Epub 2007 May 4. Erratum in: Virchows Arch. 2007 Sep;451(3):741.

PMID:
17479284
[PubMed - indexed for MEDLINE]
19.

Ductal carcinoma in situ in breast carcinogenesis.

van Diest PJ.

J Pathol. 1999 Mar;187(4):383-4.

PMID:
10398095
[PubMed - indexed for MEDLINE]
20.

Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?

Doyle B, Al-Mudhaffer M, Kennedy MM, O'Doherty A, Flanagan F, McDermott EW, Kerin MJ, Hill AD, Quinn CM.

J Clin Pathol. 2009 Jun;62(6):534-8. doi: 10.1136/jcp.2008.061457. Epub 2009 Feb 3.

PMID:
19190009
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk